… may facilitate targeted treatment and improved outcomes for localized prostate cancer. For the … successfully localized 91 percent of prostate cancer lesions, offering a threefold increase … note: For related content, see “FDA Clears AI ‘Contouring Assistant’ in …

… department of molecular and medical pharmacology at the David Geffen School … changed the landscape of prostate cancer imaging, yet treatment decisions often rely on … selection in clinical and trial interventions in prostate cancer in future major industry …

… prostate cancer, a rare and hard-to-treat form of prostate cancer … treatment for patients with prostate cancer involves repressing the main driver of prostate cancer … prostate cancer. β-catenin is notoriously difficult to target pharmacologically. …

… the intention to treat. Results During a … prostate cancer recurrence or progression and thus could be an acceptable treatment … intermediate risk localized prostate cancer. This study … trial of stereotactic body radiotherapy in localized prostate cancer. …

… were candidates for the EMBARK trial, which previously revealed that … in current clinical protocols for prostate cancer treatment. The implications of these findings … in both clinical and trial interventions concerning prostate cancer, particularly as it …

… potentially more aggressive) drug combinations or a clinical trial. Conversely, men who … worse regardless of which cancer drugs they were taking. Median survival … outcomes and potentially treatment options for men with metastatic prostate cancer," said …

… diagnosis of low-grade prostate cancer. “It came as … we treat it?” Two options were given: radiation treatment, … women going through menopause.” Medication helped manage his moods … excellent resources available, like prostate cancer groups on Facebook, …

… arises and how clinicians may treat it. Cold Spring Harbor Laboratory … had eagerly followed the ongoing trial. Although the results did not … of an MSB treatment, Trotman turned to a prostate cancer mouse model that …

… turning to similar drugs or other prescriptions, … treatments. Originally created to treat diabetes, injectable GLP-1 medications … Pharmaceuticals, which is developing a radiopharmaceutical drug, which uses radioactive isotopes to treat midstage prostate cancer …

Oral targeted therapies are a standard of care for men with advanced prostate cancer. However, these therapies are expensive, which may be a barrier to some, particularly the most economically disadvantaged. Through investment in programs to assist this …